Literature DB >> 31825002

Acute respiratory distress-syndrome in the general complications of severe acute pancreatitis.

Ravshan Aliyevich Ibadov1, Anvar Shamkhatovich Arifjanov1, Sardor Khamdamovich Ibragimov1, Bakhrom Rustamjanovich Abdullajanov2.   

Abstract

BACKGROUNDS/AIMS: Improvement of efficiency of treatment of patients with severe acute pancreatitis (SAP), complicated by acute respiratory distress-syndrome (ARDS).
METHODS: The retrospective research of 67 SAP patients treated at the ICU of the NSSPCS has been conducted from 2008 to 2017. The basic criterion of patient inclusion was stable respiration impairment leading to hypoxia with PaO2/FiO2<300 mmHg that required mechanical ventilatory support.
RESULTS: Pancreatitis-associated ARDS was diagnosed in 36 cases (53.7%). The most frequent clinical form (15 cases) was ARDS of moderate severity (41.5%). The total mortality due to pancreatitis-associated ARDS made 44.5%. Close relationship between ARDS severity and mortality was evident. All lethal outcomes occurred due to progressing multiple organ dysfunction. No deaths were caused by uncontrollable hypoxemia.
CONCLUSIONS: The research has confirmed the leading role of pancreatitis-associated ARDS in development and high mortality rate of multiple organ dysfunction syndrome in SAP. Early recognition of the complication and application of ventilatory support techniques resulted in fast restoration of oxygenation and improvement of treatment efficiency.
Copyright © 2019 by The Korean Association of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Acute respiratory distress-syndrome; Intensive therapy; Respiratory support; Severe acute pancreatitis

Year:  2019        PMID: 31825002      PMCID: PMC6893050          DOI: 10.14701/ahbps.2019.23.4.359

Source DB:  PubMed          Journal:  Ann Hepatobiliary Pancreat Surg        ISSN: 2508-5859


INTRODUCTION

Acute pancreatitis (AP) remains to be one of widely spread surgical illnesses of the gastrointestinal system. It is known to be characterized by high mortality rate, in its destructive forms in particular, which varies from 10% to 85%.12 AP necrotic forms develop due to various purulentseptic and systemic complications being the principal cause of unsatisfactory immediate results of treatment of patients with severe AP (SAP).34 SAP complications, as a rule, create a situation for a physician when the disease course become spoorly controlled, and the outcome is hardly predicted. Multiple organ dysfunction syndrome (MODS) is an integral part of SAP complications, and pancreatitis-associated acute respiratory distress-syndrome (ARDS) indicates the earliest organ dysfunction in SAP. According to various investigators, ARDS death toll makes 25–80%.5678 The basic part of intensive therapy for pancreatitis-associated ARDS is timely started and adequately performed respiratory support. It is obvious, that the success can be achieved only with the earliest possible prediction of the complication and correct selection of the complex treatment tactics using modern methods of respiratory therapy.9

MATERIALS AND METHODS

Ethical approval

The review board and ethics committee of RSSPMCS named after acad. V.Vakhidov approved the study protocol and informed consents were taken from all the participants. The research was designed on the basis of management of 67 SAP patients at the NSSPCS in 2008–2017. It included the analyses of frequency of development of pancreatitis- associated ARDS and the complication clinical course as well as evaluation of the intensive therapy efficiency and outcomes. The diagnosis criteria and assessment of AP severity were based on the third revision of the Atlanta-92 international classification (2012).2 The diagnosis of ARDS was made according to the standard criteria, i.e. acute onset, bilateral opacities on chest imaging (chest radiograph or CT), a decrease in the PaO2/FiO2 index below 300 mmHg, no signs of left ventricle failure as the principal cause of gas exchange disorder. We used the Berlin definition of ARDS (2012) made by the Conciliatory Commission “The ARDS Definition Task Force”.9 In the present research, the cases which till 2012 were interpreted as “acute lung injury” were included in the mild ARDS category. To verify the initial diagnosis and trace the subsequent development of pancreatitis-associated ARDS, computer tomography was used in addition to X-ray films, that demonstrated the areas of reduced ventilation of the lungs due to consolidation of the pulmonary tissue (Fig. 1).
Fig. 1

The initial X-ray and CT-scan of the chest of 48-year old patient with SAP complicated with pancreatitis-associated ARDS of moderate severity.

The complex intensive therapy for pancreatitis-associated ARDS was based on respiratory support performed according to the principles of “safe ventilation” and application of a step-wise technique of increasing P-control and PEEP values. It included: - the peak pressure in the respiratory tract - ≤35 cmH2O; - the respiratory volume - no greater than 6–8 ml/kg of body weight; - the minimum respiration frequency and ventilation volume per minute necessary for keeping PaCO2 at the level of 30–40 mmHg; - the velocity of the peak inspiration flow ranging from 30–40 to 70–80 L/min; - the inspiration flow profile - descending (ramped); - the minimum oxygen fraction in the respiratory gas necessary for sufficient oxygenation of arterial blood and oxygen transport to tissues; - PEEP values corresponding to “the optimum PEEP” concept with the maximum oxygen transport to tissues; - selection of auto-PEEP to avoid high auto-PEEP: <50% of the total PEEP; - the inspiration pauses duration (IP): <30% of the duration of the respiratory cycle; - the inspiration/expiration ratio inverting not more than 1.5:1; - a sedative therapy and if it is necessary - short myoplegia. Avoid hyperventilation. To achieve the set goals VELLA (Viasys Healthcare Inc.) and “Puritan Bennett 840” (General Electric, USA) were used. At the stage of the expressed impairment of gas exchange, respiratory support was used in CMV, SIMV, BIPAP, PSpatterns; preference was given to the pressurecontrol. Noninvasive ventilation was carried out in NiCPAP and NiSIMV modes. The initial level of support by inspiratory pressure (Pinsp) was 7 cmH2O with the subsequent increase up to achievement of respiratory volume of 6–8 ml/kg of due body weight. In addition, mechanical intrapulmonary percussive ventilation (IPV) with IPV-HCBI-PHASICIMPULSATOR (Percussionaire) was carried out. Constant pressure in the airways was kept at the level of 5–10 cmH2O, the respiration support pressure was 5–15 cmH2O. The following indicators were registered: Ppeak, Pinsp, Pplat, PEEP, respiratory system compliance (Crs), static compliance (Cst) and resistance of the respiratory system (Rrs). The PEEP optimum value was determined by indicators of respiratory mechanics, oxygenation and by the analysis of the pressure-volume curve. On the inspiratory part of the curve, the upper and lower bend points were verified. The the respiratory therapy efficiency was evaluated by the following criteria: paO2/FiO2>300 mmHg, a decrease in blood shunting (from right to left), pO2 (A-a) e, pO2 (a-A) e, reduction of the infiltration on the chest X-ray, dynamically increasing static compliance (Cst), restoration of cough-reflex.

RESULTS

In our research, 36 (12.4%) SAP patients had pancreatitisassociated ARDS. In 11 (30.5%) cases, ARDS was severe; moderate severity ARDS was diagnosed in 15 (41.7%) cases, and 10 (27.8 %) patients had mild ARDS. On the average, the initial paO2/FiO2 index was 155±65 mmHg. Probability of ARDS development increased in elder patients (over 50 years). Other significant risk factors are SAP purulent-septic complications, intra-abdominal hypertension that necessitated surgical operations at the initial or final stages, as well as infusion of high doses of catecholamine immediately after the surgery. All patients required from 5- to 25-day mechanical ventilation (MV). Respiratory support efficiency in all 36 clinically observed pancreatitis-associated ARDS was evaluated by the change in PaO2/FiO2values registered on the following day after MV initiation. The PaO2/FiO2 gain was calculated in percentage to the initial value, and the calculated value could be both positive (oxygenation improvement) and negative (oxygenation deterioration). Distribution of observations depending on respiratory support efficiency is presented in Fig. 2. The respiratory support with the paO2/FiO2 gain below 10% (in 6 patients) was considered in efficient. In these patients, ARDS developed as a component of MODS or sepsis. MV continuation was not accompanied by significant improvement of gas exchange; the paO2/FiO2 index has been 150–250 mmHg for a long time necessitating prolongation of respiratory support with PEEP above 10 cm H2O and FiO2 above 50%. These patients died due to progressing MODS. Among 36 patients with pancreatitis-associated ARDS, lethal outcomes occurred in 16 cases; thus, the death rate in the study group made 44.5%.
Fig. 2

Distribution of observations depending on the PaO2/FiO2 gain next day after the initiation of respiratory support.

However, we noticed the tendency to a greater gain of the PaO2/FiO2 index in the cases with early application of respiratory therapy. We have found out a regular relation between the severity of the syndrome and mortality rate. For instance, the above mentioned lethal outcomes were caused by moderate and severe pancreatitis-associated ARDS, progressing MODS with accompanied by acute cardiovascular failure at the terminal stage. In addition, over 50% of SAP patients had two and more purulent-septic complications. In 20 (55.5 %) patients, the intensive therapy with respiratory support has led to satisfactory results with resolution of pancreatitis-associated ARDS and improvement of the patient general condition. The changes in the indicators of gas exchange and respiration biomechanics resulted from the technique of a “step-wise” increase in PEEP and P-control are presented in Table 1.
Table 1

Dynamics of average indices of gas exchange during respiratory therapy for pancreatitis-associated ARDS

Significant improvement of the indices under study (PaO2 and PaO2/FiO2) contributing to reduction of FiO2 was revealed. It enabled to apply supportive artificial lung ventilation (ALV) to provide spontaneous breathing activity of the patients. In addition, some positive dynamics in oxygen alveolar-arterial (P(A-a)O2) and arterial-alveolar differences (P(a-A)O2) as well as the degree of intrapulmonary shunting (Qs/Qt) were observed. The modes of pressure-controlled respiratory support did not decline cardiac efficiency and oxygen delivery to tissues judging by the absence of SvO2 negative dynamics and lactate concentration in venous blood. The X-ray and MSCT showed considerable reduction in the infiltration areas and improvement of the lung pattern (Fig. 3).
Fig. 3

The X-ray and CT-scanning of the chest of 48-year old patient after 72 hours of respiratory support.

In 12 patients, IPV and NiCPAP were applied at the stage of transition from traditional ALV through an endotracheal tube to spontaneous breathing activity. As a result, we noted a considerable decrease in the duration of invasive ALV in comparison with the cases where the technique was not applied. Thus, the analysis of the gas exchange indicators has confirmed that it is possible to maintain adequate oxygenation using respiratory support in the modes of pressure-controlled “step-wise” technique of increasing PEEP and P-control.

DISCUSSION

Summing up the clinical and retrospective data, it is possible to draw a conclusion that pancreatitis-associated ARDS is the leading cause of MODS development in SAP and high mortality associated with it. According to the literature data, pancreatitis-associated ARDS causes 60% of all cases of death in SAP within the first week of the disease.7 Currently, SAP patient management is based on an intensive conservative therapy. It is aimed at prevention of specific complications using a supporting therapy, reduction in severity of inflammation and necrosis of the pancreas to avoid the progress of the syndrome of systemic inflammatory response.41011 Almost half a century period of studying the features of ARDS treatment enables to formulate the conceptual framework: 1) respiratory support is a basis of the ARDS intensive therapy; 2) respiratory support per se can damage the lungs and aggravate the course of the disease; 3) the tactics of respiratory support in ARDS should be individualized.12 When carrying out an ARDS respiratory therapy, generally accepted requirements are observing the “safe ventilation” concept and keeping the alveoli open.12 Application of modern technologies of respiratory support with selection of ventilation optimum parameters can reduce the number of infectious-inflammatory complications in SAP patients related to ALV. According to the results of the research, the medicaltactical algorithm of SAP patient management has been proposed (Fig. 4). It is based on evaluating and prognostic scales, application of the entire complex of medical tactics that provides the maximum opportunities for SAP intensive conservative therapy and respiratory support in pancreatitisassociated ARDS.
Fig. 4

Algorithm for the management of SAP.

Pancreatitis-associated ARDS is still an urgent clinical problem in intensive therapy for severe AP due to high incidence and mortality. Early clinical manifestations of pancreatitis-associated ARDS are occult and necessitate the dynamic control of the most objective indicators of gas exchange, daily analysis of the prognostic scales, application of modern methods of diagnosis and respiratory support. The combination of concepts of “safe ventilation” and “safe hypoxemia” with application of the “step-wise” technique of increasing P-control and PEEP results in faster restoration of oxygenation, shorter invasive respiratory support, significant reduction in frequency of ventilator-associated pneumonia. IPV used at the stage of transition to spontaneous breathing activity reliably makes noninvasive ALV shorter, accelerates activation of patients and reduces the duration of their stay in an ICU.
  12 in total

Review 1.  Pancreatitis-associated acute lung injury: new insights.

Authors:  Catherine M Pastor; Michael A Matthay; Jean-Louis Frossard
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

Review 2.  Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies.

Authors:  X Zhao; R Andersson; X Wang; M Dib; X Wang
Journal:  Scand J Gastroenterol       Date:  2002-12       Impact factor: 2.423

Review 3.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

Review 4.  Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention.

Authors:  Meng-Tao Zhou; Cheng-Shui Chen; Bi-Cheng Chen; Qi-Yu Zhang; Roland Andersson
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

5.  Update on pathogenesis and clinical management of acute pancreatitis.

Authors:  Dulce M Cruz-Santamaría; Carlos Taxonera; Manuel Giner
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

6.  Acute necrotizing pancreatitis: treatment strategy according to the status of infection.

Authors:  M W Büchler; B Gloor; C A Müller; H Friess; C A Seiler; W Uhl
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

7.  Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis.

Authors:  A Buter; C W Imrie; C R Carter; S Evans; C J McKay
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

8.  Fundamental and intensive care of acute pancreatitis.

Authors:  Morihisa Hirota; Tadahiro Takada; Nobuya Kitamura; Tetsuhide Ito; Koichi Hirata; Masahiro Yoshida; Toshihiko Mayumi; Keisho Kataoka; Kazunori Takeda; Miho Sekimoto; Masahiko Hirota; Yasutoshi Kimura; Keita Wada; Hodaka Amano; Toshifumi Gabata; Shinju Arata; Masamichi Yokoe; Seiki Kiriyama
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-12-12       Impact factor: 7.027

9.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  4 in total

1.  The changes of triacylglycerol and inflammatory factors during dialysis treatment of hypertriglyceridemia during pregnancy and analysis of nursing countermeasure.

Authors:  Lin Guo; Lingzhi Rong; Xuewei Xu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  The risk factors for acute respiratory distress syndrome in patients with severe acute pancreatitis: A retrospective analysis.

Authors:  Weiwei Zhang; Min Zhang; Zhiming Kuang; Zhenfei Huang; Lin Gao; Jianlong Zhu
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

3.  Penehyclidine hydrochloride alleviates lipopolysaccharide‑induced acute respiratory distress syndrome in cells via regulating autophagy‑related pathway.

Authors:  Xiaopeng Wang; Fen Liu; Min Xu; Liangxia Wu
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

4.  Acute Pancreatitis and Prognosticating Its Severity in Young Adults: A Case Report.

Authors:  Mallorie Vest; Harneet Grewal; Tanveer Shaukat; Ian Landry; Nso Nso; James O'Connor; Vincent Rizzo
Journal:  Cureus       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.